PNC Financial Services Group’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
RHJA
PAWC
CCIA
QC
ML
PNC Financial Services Group's OPRX Position: Q2 2026 in Review
PNC Financial Services Group increased its OptimizeRx (OPRX) stake by 1,109% in Q2 2026, buying an estimated $10.7K and bringing the position to 2,031 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4025.
PNC Financial Services Group first reported a position in OPRX in Q3 2019 and has held it in 14 quarters since. The position peaked at $136K in Q3 2019. 34 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- PNC Financial Services Group held 2,031 shares of OptimizeRx worth $11.6K as of Q2 2026.
- PNC Financial Services Group bought 1,863 OptimizeRx shares in Q2 2026, an estimated $10.7K.
- OptimizeRx made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4025 holding.
- PNC Financial Services Group first reported a position in OptimizeRx in Q3 2019 and has held it in 14 quarters since.
- PNC Financial Services Group's OptimizeRx position peaked at $136K in Q3 2019.
- 34 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.